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Abstract
Background: Isothiocyanates are natural compounds found in consumable cruciferous vegetables. They have been 
shown to inhibit chemical carcinogenesis by a wide variety of chemical carcinogens in animal models. Recent studies 
have also shown that isothiocyanates have antitumor activity, inhibiting the growth of several types of cultured human 
cancer cells. Our previous study showed that PEITC inhibited human leukemia cells growth by inducing apoptosis. 
However, the effect of isothiocyanates on lung cancer cell metastasis has not been studied. In the present study, we 
investigated the inhibitory effects of BITC and PEITC on metastatic potential of highly metastatic human lung cancer 
L9981 cells.
Methods: Cell migration and invasion were measured by wound healing assay and transwell chemotaxis assay. 
Expression of metastasis-related genes was assessed by quantitative RT-PCR and Western blotting. The mechanisms of 
action were evaluated by flow cytometry, reporter assay and Western blotting.
Results: Our data showed that both BITC and PEITC inhibited L9981 cell growth in a dose-dependent manner, the IC50 
values were 5.0 and 9.7 μM, respectively. Cell migrations were reduced to 8.1% and 16.5% of control, respectively; and 
cell invasions were reduced to 2.7% and 7.3% of control, respectively. Metastasis-related genes MMP-2, Twist and β-
catenin were also modulated. BITC and PEITC inhibited cell survival signaling molecules Akt and NFκB activation. 
Moreover, BITC and PEITC increased ROS generation and caused GSH depletion. Pretreatment with NAC blocked BITC 
and PEITC induced ROS elevation and NFκB inhibition.
Conclusion: Our results indicated that BITC and PEITC suppress lung cancer cell metastasis potential by modulation of 
metastasis-related gene expression, inhibition of Akt/NFκB pathway. Induction of oxidative stress may play an 
important role.
Background
Lung cancer is the most common cancer worldwide, with
approximately 1.3 million cases recorded annually [1].
Furthermore, lung cancer is the leading cause of cancer-
related deaths and is responsible for 1.18 million deaths
annually [2]. The 5-year relative survival rate is approxi-
mately 15% [3]. Most patients present with locally
advanced (37%) or metastatic (38%) disease at the time of
diagnosis [4]. Surgery, chemotherapy and radiation have
been generally unsatisfactory, especially in the treatment
of advanced disease. As 90% of lung cancer patients die of
metastasis [5], metastasis is of great importance to the
clinical management.
Metastasis is an extraordinarily complex process, sev-
eral discrete steps are discernable in the biological cas-
cade of metastasis: loss of cellular adhesion, increased
motility and invasiveness, entry and survival in the circu-
lation, exit into new tissue, and eventual colonization of a
distant site [6]. A wide variety of factors contributing to
the spread of tumor cells includes cytokines, hormones,
growth factors, cell adhesion molecules, and extracellular
matrix proteins [7]. To date, the mechanism of metastasis
is unclear, new strategies based on better understanding
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of the mechanism are clearly needed to improve the
treatment efficacy of this fatal disease.
Numerous studies support the fact that phytochemicals
found in certain food substances protect against cancer.
C r u c i f e r o u s  v e g e t a b l e s  h a v e  b e e n  w i d e l y  a c c e p t e d  a s
potential diet components that may decrease the risk of
cancer [8]. Isothiocyanates are abundant in cruciferous
vegetables such as broccoli, watercress, Brussels sprouts,
cabbage, Japanese radish and cauliflower, they play a sig-
nificant role in cancer chemopreventive activity of these
vegetables. Some isothiocyanates derived from crucifer-
ous vegetables, such as phenethyl isothiocyanate
(PEITC), benzyl isothiocyanat (BITC), sulforaphane
(SFN) are highly effective in preventing or reducing the
risk of cancer induced by carcinogens in animal models
[9]. The mechanisms of cancer chemopreventive activity
of isothiocyanates are the inhibition of phase I enzymes
cytochrome P-450s involved in the activation of carcino-
gen and/or induction of phase II detoxifying enzymes,
such as glutathione S-transferases, quinone reductase,
and UDP-glucuronosyltransferases [9]. The induction of
phase II enzymes is mediated by Nrf2-dependent path-
way [10]. Recent studies have also shown that isothiocya-
nates have antitumor activity, inhibiting the growth of
several types of cultured human cancer cells. Isothiocya-
nates induce cancer cell apoptosis [11], cell cycle arrest
[12], generation of reactive oxygen species (ROS) [12,13],
regulate the activation of transcription factors STAT3,
NFκB and Nrf2 [10,14,15], inhibit MAPK and PKC activi-
ties [12,16], down-regulate estrogen receptor [17] etc.
However, the mechanism is not fully understood.
In this study, we focused on two isothiocyanates: BITC
and PEITC (Figure 1), investigated their inhibitory activi-
t i e s  o n  l u n g  c a n c e r  c e l l  m e t a s t a s i s  p o t e n t i a l .  W e  h a v e
established a pair of highly metastatic human large cell
lung cancer cell line L9981 and low metastatic cell line
NL9980, and examined the effect of BITC and PEITC on
cell proliferation, invasion, migration, and expression of
metastasis-related genes.
Methods
Materials
PEITC, BITC, NAC were purchased from Sigma Chemi-
cal Co. (S t. Louis, MO). Rabbit monoclonal an tibodies
against Twist, MMP-2, polyclonal antibodies against Akt,
p-Akt were purchased from Cell Signaling (Beverly, MA),
mouse monoclonal antibody against β-actin were pur-
chased from SIGMA, secondary antibodies coupled to
HRP were purchased from ZSGB-BIO (Beijing, China).
Trizol was purchased from Invitrogen (Carlsbad, CA),
reverse transcription kit and real-time PCR kit were pur-
chased from TaKaRa Biotechnology Co. (Dalian, China).
pNFκB-luc was purchased from Clontech (Mountain
View, CA), pRL-SV40 was purchased from Promega
(Madison, WI).
Cell lines
Highly metastatic cell line L9981 and low metastatic cell
line NL9980 were established from a human lung large
cell carcinoma cell line (WCQH29801) [18]. Cells were
grown and maintained in RPMI-1640 medium supple-
mented with 10% fetal bovine serum, 2 mmol/L glu-
tamine (GIBCO BRL, Grand Island, NY) at 37°C, 5% CO2.
Penicillin and streptomycin were not added into culture
medium to avoid the cross effects with isothiocyanates.
Cell proliferation assay
Cells were seeded at an initial density of 2 × 105 cell/mL
and incubated with 1 - 40 μM PEITC or BITC for 48 h at
37°C. Stock solutions of the compounds (100 mM) were
prepared in DMSO and diluted into the growth medium
such that the final concentration of DMSO did not
exceed 0.05% (v/v), a concentration that did not induce
toxicity in L9981 or NL9980 cells. The cell viability were
determined by Vi-CELL Cell Viability Analyzer (BECK-
MAN COULTER, Brea, CA), following the manufacture's
instruction. The median inhibitory concentration IC50
values were calculated using GraphPad Prism 5.0 soft-
ware (La Jolla, CA).
Would healing assay
Cell migration was examined using a wound healing
assay. Cells were cultured in six-well plates to 100% con-
fluence. A plastic pipette tip was used to generate a clean
wound area across the center of the well. Cell debris was
removed by washing with PBS, and cells were allowed to
migrate in the medium. The wound was assessed by a
microscope (Nikon, Tokyo, Japan) at ×40 magnification at
indicated time points. Cells in each field of view were
counted by photographing through the microscope, and
the average number of cells present in each scrape with
each treatment was determined. At least five wound areas
were investigated on each plate to quantify the migration.
Cell invasion assay
The tumor cell invasion activity was assessed by Cell
Invasion Kit (CHEMICON INTERNATIONAL Inc., Bill-
erica, MA). It was performed in an Invasion Chamber, a
24-well tissue culture plate with cell culture inserts. The
Figure 1 Structures of BITC and PEITC.
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inserts contain an 8 μm pore size polycarbonate mem-
brane, over which a thin layer of ECMatrixTM is dried.
L9981 cells were suspended to a final concentration of 2 ×
105 cell/mL in serum free medium with 0.1% BSA. Cell
suspensions (300 μL) were added to the upper compart-
ment, medium collected from NIH3T3 cell culture was
added with 0.1% BSA, then added to the lower compart-
ment, and incubated for 24 h at 37°C in 5% CO2 atmo-
sphere. Invasive cells on lower surface of the membrane
were stained following the manufacturer's instruction,
and counted by photographing the membrane through
the microscope (×200 magnification).
Western blotting analysis
Western blottings were performed as previously
described [19]. Briefly, L9981 cells were incubated with
PEITC or BITC for 24 h, washed with PBS, and the cell
pellets were lysed in lysis buffer (20 mM Tris (pH7.5), 150
mM NaCl, 1% Triton X-100, sodium pyrophosphate, β-
glycerophosphate, EDTA, Na3VO4, leupeptin) (Beyotime
Institute of Biotech, Jiangsu, China) for 30 min on ice.
Lysates were centrifuged (15,000 g, 20 min, 4°C). Five-
fold concentrated SDS sample buffer (Beyotime Institute
of Biotech, Jiangsu, China) was added to cell lysates,
boiled for 5 min, and electrophoresed on a 12% SDS-
polyacrylamide gel. Protein molecular weight standards
(Bio-Rad, Richmond, CA) were run concurrently. Pro-
teins were transferred electrophoretically to nitrocellu-
lose membranes. Membranes were blocked for 1 hour at
room temperature with 5% milk protein, 0.1% Tween 20
in PBS (PBS-Tween), then were probed with rabbit anti-
Twist, MMP-2, Akt, p-Akt antibodies at 1:1000 dilution
in PBS-Tween with 5% BSA overnight at 4°C. After wash-
ing, membranes were probed with HRP-conjugated goat
anti-rabbit antibody at 1:5000 dilution in PBS-Tween
with 3% milk protein for 1 hour. After washing, blots were
developed with the Phototope HRP Western Blot Detec-
tion system (Cell Singaling).
Reverse transcription
Total RNA was extracted from cells using Trizol (Invitro-
gen, Carlsbad, CA). Reverse transcription was performed
as preciously described [19] using TaKaRa kit following
manufacturer's instruction, in the DNAEngine Peltier
Thermal Cycler (BIO-RAD, Richmond, CA). Briefly,
RNA and random primers were denatured for 10 min at
70°C; then M-MLV reverse transcriptase, deoxynucle-
otide triphosphates, RNase inhibitor and reverse tran-
scription buffer were added and incubated for 10 min at
30°C, 60 min at 42°C and 15 min at 70°C.
Real-time PCR
Primers were synthesized by SBS Genetech (Beijing,
China). SYBR Green was used to quantify mRNA levels.
All the real-time PCR reagents were purchased from
TaKaRa Biotechnology Co. (Dalian, China). PCR reac-
tions were performed as preciously described [19].
Briefly, PCR reactions were performed at the following
conditions: 10 seconds at 95°C, then 40 cycles at 95°C for
5 seconds and 65°C for 34 seconds in the ABI Prism 7500
Sequence Detector System (ABI, Foster City, CA). The
primers for MMP-2 were 5"-CTTCCAAGTCTGGAGC-
GATGT-3" (foward) and 5"-TACCGTCAAAGGGG-
TATCCAT-3" (reverse), which amplified a product of 119
bp. The primers for β-catenin were 5"-GCTGGGACCT-
TGCATAACCTT-3" (foward) and 5"-ATTTTCACCAG-
GGCAGGAATG-3" (reverse), which amplified a product
of 86 bp. The primers for Twist were 5"-GCCAATCAGC-
CACTGAAAGG-3" (foward) and 5"-TGTTCTTATAGT-
TCCTCTGATTGTTACCA-3" (reverse), which amplified
a product of 83 bp. Glyceraldehyde-3-phoshate dehydro-
genase (GAPDH) was used for normalization. The
GAPDH primers were 5"-CCACCCATGGCAAATTCC-
3" (foward) and 5"-GATGGGATTTCCATTGATGACA-
3" (reverse), which amplified a product of 71 bp.
Measurement of reactive oxygen species (ROS)
DCFH-DA fluorescent probes were used to measured the
intracellular generation of hydroperoxide (H2O2) and
superoxide anions (O2
·-), respectively, using Reactive
Oxygen Species Assay Kit (Beyotime Institute of Biotech,
Jiangsu, China), following the manufacture's instruction
[20]. Briefly, L9981 cells were incubated with or without
BITC or PEITC for 4 h, then reacted with 10 μM of
DCFH-DA for 30 min at 37°C. The ROS levels were
detected by flow cytometry. The fluorescence was mea-
sured at excitation 488 nm and emission 525 nm.
Measurement of glutathione (GSH)
DTNB were used to measure the intracellular GSH by
Total Glutathione Assay Kit (Beyotime Institute of Bio-
tech, Jiangsu, China), following the manufacture's
instruction [21]. Briefly, L9981 cells were incubated with
or without BITC or PEITC for 3-24 h, cell lysates were
prepared, and reacted with assay solution for 5 min at
25°C. The absorbance at A412 was measured on a Spectra
Max M5 microplate reader (Molecular Devices, Sunny-
vale, CA). The GSH concentrations were determined by
comparison with standards.
DNA transfection
Transfection of L9981 cells was carried out using lipo-
fectamine 2000 (Invitrogen, Carlsbad, CA), following the
manufacture's instruction. Briefly, L9981 cells were plated
in a 24-well plate at 1 × 105 cell/well. Cells were co-trans-
fected with 400 ng of pNFκB-luc, and 4 ng of pRL-SV40
a s  a n  i n t e r n a l  c o n t r o l .  C e l l s  w e r e  r e s t e d  f o r  8  h  a f t e r
transfection, then were incubated with or without BITCWu et al. BMC Cancer 2010, 10:269
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or PEITC for 18 h. Luciferase assay were performed using
the Dual-luciferase Reporter Assay System (Promega) fol-
lowing the manufacture's instruction, on BERTHOLD
TriStar LB 941 (BERTHOLD TECHNOLOGIES, Bad
Wildbad, Germany)
Statistical analysis
The data were presented as mean ± standard deviation
(S.D.). IC50 is the median growth inhibitory concentration
value, calculated using GraphPad Prism 5.0 software (La
Jolla, CA). Variance analysis between groups was per-
formed by one-way ANOVA and significance of differ-
ence between control and treatment groups was analyzed
using Dunnett multiple comparison test. The differences
with p < 0.05 were considered statistically significant.
Results
Effect of isothiocyanates on growth of L9981 cells and 
NL9980 cells
To study lung cancer cell metastasis, a proper metastatic
cell model is important. We have established a pair of
highly metastatic cell line L9981 and low metastatic cell
line NL9980, from a human lung large cell carcinoma cell
line (WCQH29801) by the single cell cloning technique
[18]. Using this model, we investigate the effect of isothi-
ocyanates on lung cancer cell metastasis. When BITC
and PEITC were incubated with low metastatic NL9980
cells, there was a dose-dependent inhibition of cell
growth. Both compounds inhibited the growth of
NL9980 cells with similar potency: the IC50 values were
8.8 ± 0.15 μM for BITC, and 12.2 ± 0.82 μM for PEITC.
BITC was more effective than PEITC (Figure 2). BITC
and PEITC had a similar effect on the growth of highly
metastatic L9981 cells, the IC50 values were 5.0 ± 0.22 μM
and 9.7 ± 0.39 μM, respectively. Again, BITC was more
effective than PEITC. When compared the inhibitory
effect of isothiocyanates on highly metastatic cell line
L9981 and low metastatic cell line NL9980, we found that
isothiocyanates were slightly more potent on highly met-
astatic cells than low metastatic cells. As this study was to
investigate the effect of isothiocyanates on lung cancer
cell metastasis potential, the further studies were focused
on the highly metastatic cell line L9981. The doses we
used were the IC50 values of BITC and PEITC.
Effect of isothiocyanates on migration of highly metastatic 
L9981 cells
W e  e x a m i n e d  t h e  e f f e c t  o f  B I T C  a n d  P E I T C  o n  t h e
migration of L9981 cells by wound healing assay. The
doses we used were the IC50 values of BITC and PEITC,
which did not cause cell death during the experiment.
When L9981 cells were incubated with BITC and PEITC,
the cellular motility were inhibited in a time-dependent
manner. As shown in Figure 3, BITC at 5 μM and PEITC
at 10 μM effectively inhibit cell migration after 24 and 30
h incubation, migration levels were reduced to 11.1% and
19.4% of control after 24 h (P < 0.001), respectively; and
8.1% and 16.5% of control after 30 h (P < 0.001), respec-
tively (Figure 4).
Effect of isothiocyanates on invasion of highly metastatic 
L9981 cells
Invasion is another important step for metastasis. We
assessed the inhibitory effect of BITC and PEITC on the
ability of L9981 cells to invade a reconstituted extracellu-
lar matrix (ECM). BITC and PEITC inhibited cell inva-
sion in a dose-dependent manner. When L9981 cells were
grown on Matrigel, a significant reduction in the number
of invasive cells was observed when the cells were treated
with BITC or PEITC for 24 h, compared to the control.
The levels of invasion were reduced to 2.7% and 7.3% of
control levels at 5 μM of BEITC and 10 μM of PEITC (P <
0.001), respectively (Figure 5). A significant reduction in
invasion was not observed when the cells were treated
with lower doses of BITC or PEITC.
Modulation of metastasis-related genes
MMP-2, Twist and β-catenin play important roles in lung
cancer metastasis. MMP-2 and Twist  promote metasta-
sis; whereas β-catenin inhibits metastasis. As BITC and
PEITC inhibited L9981 cells migration and invasion, we
further investigated their effects on these metastasis-
related genes. L9981 cells were treated with 5 μM of BITC
or 10 μM of PEITC for 4 h, the mRNA expression levels of
these three genes were detected by real-time PCR.
mRNA expression levels of pro-metastasis gene MMP-2
were reduced to 32% and 51% of control by BITC and
PEITC (P < 0.05), respectively; mRNA expression levels
of pro-metastasis gene Twist  were reduced to 35% and
43% of control by BITC and PEITC (P < 0.01), respec-
tively. Whereas mRNA expression levels of anti-metasta-
sis gene β-catenin were increased. They were increased
2.4- and 2.1-fold by BITC and PEITC (P < 0.001), respec-
Figure 2 Effects of BITC and PEITC on growth of highly and low 
metastatic cells. L9981 and NL9980 cells were treated with 1 - 40 μM 
of BITC or PEITC for 48 h, and were collected and counted by a Vi-CELL 
Cell Viability Analyzer. Values represent the mean ± SD from three in-
dependent measurements.
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tively (Figure 6A). We further detected the protein
expression of these genes. Western blotting data demon-
strated that both MMP-2 and Twist expression were
reduced by BITC and PEITC, in a dose-dependent man-
ner (Figure 6B). These results were consistent with
migration and invasion assay results.
Effect of isothiocyanates on ROS generation
We investigated whether the generation of intracellular
ROS is part of the mechanism by which isothiocyanates
suppress the metastasis potential of lung cancer L9981
cells. The generation of ROS by isothiocyanates was
assessed by using fluorescent probes DCFH-DA by flow
cytometry. Treatment with 5 μM of BITC or 10 μM
PEITC showed similar effects, resulted in an increase in
ROS levels, compared with control (Figure 7). However
these were only short term treatments. After a prolonged
time, when the Nrf2 targeted genes are expressed, the
amount of ROS could decrease. We further investigated
the effect of antioxidant NAC on ROS generation. NAC
(1 mM) was added to the medium 1 h prior to isothiocya-
nate treatment, and remained in the medium throughout
the experiments. Pretreatment with NAC completely
blocked the increased ROS generation induced by both
BITC and PEITC.
Effect of isothiocyanates on intracellular glutathione levels
Glutathione is an intracellular antioxidant, helps protect
cells from ROS such as free radicals and peroxides.
Whether isothiocyanates exacerbated oxidative stress by
causing depletion of intracellular glutathione was investi-
gated. Our data showed both BITC and PEITC decreased
total GSH concentration in a dose-dependent manner,
but the total GSH concentration in control incubations
Figure 3 Effect of BITC and PEITC on L9981 cells migration. Wound healing assays were performed to assess cell migration. Cells were treated or 
untreated with 5 μM of BITC or 10 μM of PEITC for 24 and 30 h. Representative photographs of treated and untreated cells are presented (×40 mag-
nification).
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did not change significantly. When L9981 cells were incu-
bated with 5 or 10 μM of BITC, there was a decrease in
total GSH concentration in the initial 3 h of incubation,
and continues to decrease till 6 h, but by 12 h had recov-
ered to high level. Thereafter, a further marked decrease
occurred until 24 h (Figure 8). When L9981 cells were
incubated with 5 or 10 μM of PEITC, total GSH concen-
tration decreased in the 3 to 6 h period. Similar to BITC
treatment, they were recovered to high level at 9 or 12 h,
respectively. Then declined again and remained at low
levels thereafter.
Effect of isothiocyanates on Akt activation
Akt is an important cell signaling molecule. It blocks
apoptosis, and promotes cell survival. Akt has been impli-
cated as a major factor in many types of cancer. To evalu-
ate whether Akt is a target of isothiocyanate on inhibition
of lung cancer cell metastasis, we detected the Akt activa-
tion by western blotting (Figure 9). Both BITC and PEITC
decreased Akt phosphorylation, in a dose-dependent
Figure 4 Effect of BITC and PEITC on L9981 cells migration. 
Wound healing assays were performed to assess cell migration. Cells 
were treated or untreated with 5 μM of BITC or 10 μM of PEITC for 24 
and 30 h. Number of cells migrated at 24 and 30 h time point are pre-
sented. Values represent the mean ± SD of three independent experi-
ments (*** P < 0.001).
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manner. At high concentrations, PEITC (20 μM) and
BITC (10 μM) nearly completely blocked Akt phosphory-
lation; meanwhile, total Akt level remained unchanged.
Effect of isothiocyanates on NFκB transcriptional activation
The nuclear factor kappa B (NF-κB) is believed to play an
important role in tumor cell growth, proliferation, angio-
genesis, invasion, apoptosis and survival. In this study, we
investigated the effects of BITC and PEITC on NF-κB
transcriptional activation, by luciferase reporter assay. As
shown in Figure 10, both BITC and PEITC inhibited the
transcriptional activation of NF-κB in a dose-dependent
manner. After treatments for 18 h, compared with con-
trol, 10 and 20 μM of PEITC significantly inhibited the
transcriptional activity of NF-κB to 64.5 and 30.5% of
control (P < 0.05), respectively. Similar to PEITC, 5 and
10 μM of BITC significantly inhibited the transcriptional
activity of NF-κB to 30.8 and 6.8% of control (P < 0.001),
respectively. We further investigated the protective effect
of antioxidant NAC. Pretreatment with antioxidant NAC
(1 mM) for 1 h significantly attenuated the inhibitory
effect of BITC and PEITC on NF-κB transcriptional acti-
vation (P < 0.05).
Discussion
The antiproliferative, antitumour activity of dietary iso-
thiocyanates has been of recent research interest [9].
These compounds have inhibitory effects on several types
of cancer cell growth, such as leukemia [22,23], prostate
cancer [14], breast cancer [11,17], lung cancer [24], cervi-
cal cancer [16], colorectal cancer [15] etc. Our previous
studies have demonstrated that allyl isothiocyanate
(AITC), PEITC, PETC-Cys and related compounds
Figure 6 Effect of BITC and PEITC on metastasis-related gene ex-
pression. (A) L9981 cells were treated with 5 μM of BITC or 10 μM of 
PEITC for 4 h. MMP-2, Twist and β-catenin mRNA expressions were de-
tected by real-time PCR. (B) L9981 cells were treated with 5 - 20 μM of 
BITC or PEITC for 24 h. MMP-2 and Twist protein expression were de-
tected by Western blotting analyses (* P < 0.05, ** P < 0.01, *** P < 
0.001). Similar results were obtained in three independent experi-
ments.
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induce apoptosis in HL60 cells [22,25]. The activation of
caspases and JNK are part of the mechanism [23].
Metastasis is the most common cause of death in can-
cer patients. Therefore, the research and development of
novel anti-metastatic drugs is one of the most active
fields in cancer research. Recent studies revealed that iso-
thiocyanates have anti-angiogenic and anti-metastatic
effects. Isothiocyanates inhibited tumor-specific angio-
genesis by down-regulating nitric oxide, TNF-alpha and
proinflammatory cytokine production, and by inactiva-
tion of Akt [26-28]. Isothiocyanates also suppressed the
metastasis potential of human hepatoma cells [29], colon
cancer cells [30] and breast cancer cells [31]. This effect is
mediated by decreasing the expression of MMPs, pro-
inflammatory cytokines, growth factors such as platelet-
derived growth factor (PDGF) and vascular endothelial
growth factor (VEGF), transcription factor twist; and
increasing the expression of tissue inhibitors of matrix
metalloproteinase (TIMPs). However, there is no report
on the effect of isothiocyanates on lung cancer metasta-
sis. In the present study, we investigated the effect of
BITC and PEITC on lung cancer cell metastasis potential,
by using a highly metastatic human large cell lung cancer
cell line as an in vitro model.
Figure 8 Effect of BITC and PEITC on intracellular GSH levels. L9981 cells were treated with 5 or 10 μM of BITC or PEITC for 3 - 24 h, intracellular 
total GSH levels were detected at indicated time points by microplate reader. Values represent the mean ± SD of three independent experiments.
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We performed wound healing and transwell chamber
assays to examine the effect of BITC and PEITC on lung
cancer cell metastasis potential, at the concentrations
which did not cause cell death during the assays. Our
results clearly demonstrate for the first time, that both
BITC and PEITC effectively inhibit lung cancer cell
migration and invasion in vitro. We then detected the
effect of isothiocyanates on metastasis-related gene
expression. MMPs are a family of zinc-binding endopep-
tidases that collectively degrade most of the components
of extracellular matrix (ECM), and they are necessary for
cancer invasion and metastasis [32]. In particular, MMP-
2 degrades components of the basement membrane and
is strongly implicated in the invasion and metastasis of
malignant tumors [32]. Our data showed that BITC and
PEITC reduced MMP-2 expression at both mRNA and
protein level. Transcription factor Twist is a key regulator
of tumor metastasis and an inducer of epithelial-mesen-
chymal transition. It plays an essential role in metastasis.
Twist over-expression correlates with hepatocellular car-
cinoma metastasis. Suppression of Twist expression in
highly metastatic mammary carcinoma cells specifically
inhibits its metastatic ability [33,34]. In our study, BITC
and PEITC down-regulated Twist expression at both
mRNA and protein levels. Another metastasis correlated
gene we examined is β-catenin. β-catenin is an epithelial
marker, it is necessary for the creation and maintenance
of epithelial cell layers. It is down-regulated during lung
cancer cell invasion and metastasis [35]. We found that
when BITC and PEITC suppressed cell metastasis poten-
tial, β-catenin expression was increased. Taken together,
these data indicated BITC and PEITC suppressed lung
cancer cell metastasis potential by modulating metasta-
sis-related gene expression.
To further explore the underlying mechanism, we
investigated the effect of BITC and PEITC on cell survival
pathways. Akt/NFκB is a major anti-apoptotic/pro-sur-
vival pathway that is frequently hyperactivated in most
cancers [36,37]. Akt phosphorylation promotes cell
growth and survival by inactivating downstream pro-
apoptosis substrates such as Bad, caspases, and activating
cell survival substrates such as NFκB. Both clinical analy-
sis and in vivo studies showed that Akt plays an important
role in cancer cell metastasis [38,39]. NFκB is a transcrip-
tion factor that is activated by various intra- and extra-
cellular stimuli such as cytokines, oxidant-free radicals,
ultraviolet irradiation, and bacterial or viral products. It
controls the expression of numerous genes involved in
immune and inflammatory responses, cell proliferation,
oncogenesis, angiogenesis and apoptosis. Inhibition of
NFκB activation effectively suppressed tumor cell inva-
sion [40]. More interestingly, recent studies suggested
that the activation of Akt/NFκB pathway contribute to
the migration of lung cancer cell [41,42]. In this study, we
examined the effect of BITC and PEITC on Akt/NFκB
pathway. BITC and PEITC inhibited both Akt phospho-
rylation and NFκB transcriptional activation, in a dose-
dependent manner. This suggested that Akt/NFκB path-
way is a potential target of BITC and PEITC.
The altered cellular redox status and increased genera-
tion of ROS have long been observed in cancer cells,
especially the cells in advanced stage tumor, which
exhibit multiple genetic alterations and high oxidative
stress. This drives us to investigate the effect of isothiocy-
anates on ROS generation. ROS is generated intracellu-
larly as byproducts of normal aerobic metabolism or as
second messengers in various signal transduction path-
ways or in response to environmental stress. ROS is
essential for biological functions. They regulate many sig-
nal transduction pathways by directly reacting with and
modifying the structure of proteins, transcription factors
and genes to modulate their functions. ROS is involved in
signalling cell growth and differentiation, regulating the
activity of enzymes, mediating inflammation by stimulat-
ing cytokine production, and eliminating pathogens and
foreign particles [43]. Cancer cells frequently exhibit high
oxidative stress. The generation of ROS is part of the
mechanism by which most chemotherapeutic agents or
ionizing radiation kill tumor cells [44,45]. Recent studies
demonstrate that ROS also plays an important role in cell
invasion. It regulates cell invasion via MMPs expression,
MAPK pathways and NFκB activation [46-48]. In this
study, we investigated the role of ROS in isothiocyanate-
induced inhibition of lung cancer cell metastasis. Our
finding provide evidence of the generation of ROS by
BITC and PEITC in lung cancer highly metastatic cells,
this is consistent with studies in other type of cancer, such
as leukaemia [49], breast cancer [13] and pancreatic can-
cer [12]. The hypothesis of the increased generation of
ROS in response to BITC and PEITC was further sup-
ported by the finding that pretreatment with NAC, a gen-
eral antioxidant, blocked the ROS accumulation. NAC
pretreatment also blocked the suppression of NFκB acti-
vation, this is in agreement with the finding that ROS-
N F κ B  p a t h w a y  m e d i a t e s  T G F - b e t a 1 - i n d u c e d  c e l l  i n v a -
sion [48]. It has been described that isothiocynates cause
release of Nrf2 from sequestration by Keap1, and its sub-
sequent translocation into the nucleus. Nuclear Nrf2 acti-
vates ARE-elements and induces expression of stress-
responsive genes [10]. Although for short term treatment
the ROS level increases, we expect that after a long term
treatment, the ROS level will decrease due to induction of
Nrf2 dependent detoxification and antioxidative genes.
We suggested that ROS generation may play a role in the
inhibitory activity of isothiocyanates on lung cancer
metastasis.
GSH is an antioxidant, helps protect cells from ROS
s u c h  a s  f r e e  r a d i c a l s  a n d  p e r o x i d e s ,  i t  a l s o  m a i n t a i n s
exogenous antioxidants such as vitamins C and E in their
reduced (active) forms. PEITC is known to conjugateWu et al. BMC Cancer 2010, 10:269
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with GSH, leading to its exportation and depletion of cel-
lular GSH. Depletion of cellular GSH leads to ROS accu-
mulation. This is thought to be a major mechanism of
PEITC-induced ROS stress in cancer cells. Our previous
study showed that GSH depletion is involved in leukae-
mia cell apoptosis induced by PEITC and its cysteine con-
jugate [50], a current study showed that GSH
concentration was decreased by BITC and PEITC. There
were recoveries at 9 and 12 h time points, however, this
may be due to the stimulated GSH synthesis when cells
detected the GSH level was low. After 24 h, GSH concen-
tration decreased again, this is probably because the dys-
function of cellular GSH synthesis system. Some tumor
cells have higher GSH level, this is due to the over-expres-
sion of Gamma-glutamyl transpeptidase and an interor-
gan flow of GSH. The higher GSH level promotes
metastatic growth [51]. This suggested that GSH may
play a role in tumor cell metastasis. Therefore GSH can
be a target for metastasis treatment. In supporting this
hypothesis, Mena et al sensitized B16 melanoma to com-
bination therapy and eliminates metastatic disease by
GSH depletion [52]. Our finding that BITC and PEITC
decreased GSH level while suppressed tumor cell metas-
tasis potential, also support this hypothesis.
Our results demonstrate that BITC and PEITC inhib-
ited lung cancer highly metastatic L9981cell proliferation,
migration and invasion. Metastasis-related genes were
modulated and Akt/NFκB pathway was inhibited. Oxida-
tive stress could be part of the mechanism by which iso-
thiocyanates suppressed lung cancer cell metastasis
potential.
Conclusion
Isothiocyanates are well-known chemopreventive agents.
Understanding the mechanism of action of these com-
pounds may provide valuable information for their possi-
ble application in cancer prevention and therapy. There
are already a number of studies that evaluate the effects of
isothiocyanates in human subjects [53-55], this could
potentially facilitate clinical development of isothiocya-
nates for cancer therapy.
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